{"id":749,"date":"2026-09-01T16:45:45","date_gmt":"2026-09-01T16:45:45","guid":{"rendered":"https:\/\/nhdbio.com\/resources\/ara-290-cibinetide-small-fiber-neuropathy-and-dme-trials\/"},"modified":"2026-10-01T14:51:45","modified_gmt":"2026-10-01T14:51:45","slug":"ara-290-studien-zu-cibinetid-bei-neuropathie-der-kleinen-nervenfasern-und-dme","status":"publish","type":"post","link":"https:\/\/nhdbio.com\/de\/ara-290-cibinetide-small-fiber-neuropathy-and-dme-trials\/","title":{"rendered":"ARA-290\/Cibinetide: Small-Fiber-Neuropathie und DME-Studiendaten"},"content":{"rendered":"

Die Evidenz f\u00fcr humanes Cibinetid umfasst kleine explorative Studien mit sehr unterschiedlichen Populationen. Ein 22-Pilotprojekt zur Sarkoidose-Neuropathie berichtete \u00fcber einen Unterschied in der Symptombewertung, w\u00e4hrend in einer 9-Studie zu Diabetikern und Makula\u00f6demen die wichtigsten Augenmessungen verfehlt wurden.<\/p>

Beweise auf einen Blick<\/h2>
  • Der randomisierte Sarkoidose-Pilot rekrutierte 22-Teilnehmer: 12 erhielt ARA-290- und 10-Placebo.<\/li>
  • Die SFNSL-\u00c4nderung in der Woche 4 betrug \u221211.5 \u00b1 3.04 gegen\u00fcber \u22122.9 \u00b1 3.34, w\u00e4hrend sich die Schmerzintensit\u00e4ts- und Erm\u00fcdungswerte in beiden Gruppen \u00e4hnlich verbesserten.<\/li>
  • In die DME-Studie wurden 9 aufgenommen und 8 abgeschlossen; Die mittlere Sehsch\u00e4rfe, die Netzhautdicke, die Netzhautempfindlichkeit und die Tr\u00e4nenproduktion verbesserten sich nicht.<\/li><\/ul><\/div><\/div>
    \"Forschungsbildgebung
    Originale redaktionelle Forschungsillustration. Es handelt sich nicht um eine Studienfigur, ein Patientenbild, ein Produktfoto, ein geliefertes Testergebnis oder eine Darstellung einer Katalogcharge.<\/figcaption><\/figure>

    Studienprotokoll<\/h2>

    Der Neuropathie-Pilot berichtete \u00fcber eine statistisch signifikante \u00c4nderung zwischen den Gruppen in der Screeningliste f\u00fcr Neuropathie kleiner Fasern. Allerdings verbesserten sich das Kurzschmerzinventar und die Erm\u00fcdungswerte in beiden Gruppen deutlich, aber gleichwertig, und das Depressionsinventar \u00e4nderte sich nicht.<\/p>

    Sarkoidose-Design<\/strong>Doppelblindes, placebokontrolliertes Pilotprojekt; n=22<\/span><\/div>
    SFNSL \u00c4nderung<\/strong>\u221211.5 \u00b1 3.04 gegen\u00fcber \u22122.9 \u00b1 3.34 in der Woche 4<\/span><\/div>
    DME-Design<\/strong>Einarmige Phase 2; 9 eingeschrieben, 8 abgeschlossen<\/span><\/div>
    DME Hauptma\u00dfe<\/strong>Keine mittlere Verbesserung der BCVA, CRT, Netzhautempfindlichkeit oder Tr\u00e4nenproduktion<\/span><\/div>
    Gesamtinterpretation<\/strong>Signale generieren Hypothesen und sind nicht best\u00e4tigend<\/span><\/div><\/div><\/div>

    Ergebnisse im Kontext<\/h2>

    Die 2020-Studie zum diabetischen Makula\u00f6dem war sogar noch kleiner. In den 12-Wochen \u00e4nderte sich der mittlere BCVA um \u22122.9 \u00b1 5.0, die zentrale Netzhautdicke um 10 \u00b1 94.6 \u00b5m und die zentrale Netzhautempfindlichkeit um \u22120.53 \u00b1 1.9 dB. Ein vom Patienten berichtetes visuelles Funktionskomposit, verbessert durch 2.7 \u00b1 3.1, aber das Design war beschreibend und unkontrolliert.<\/p>

    Mehrere Autoren des DME-Papiers waren leitende Angestellte, Eigent\u00fcmer oder Berater des Entwicklers. Diese Offenlegung macht die Ergebnisse nicht ung\u00fcltig, geh\u00f6rt aber neben die Daten, wenn Leser einen kleinen Sondierungsversuch beurteilen.<\/p>

    Was die Beweise nicht belegen k\u00f6nnen<\/h2>

    Kleine Stichproben und kurzes Follow-up machen Effektsch\u00e4tzungen instabil.<\/p>

    Verschiedene Krankheiten und Endpunkte k\u00f6nnen nicht in einem umfassenden \u201eNervenreparatur\u201c-Anspruch zusammengefasst werden.<\/p>

    Keine der beiden Studien stellt eine Gleichwertigkeit mit einem Katalogmaterial her oder unterst\u00fctzt die Verwendung au\u00dferhalb der Forschung.<\/p>","protected":false},"excerpt":{"rendered":"

    Die Evidenz f\u00fcr humanes Cibinetid umfasst kleine explorative Studien mit sehr unterschiedlichen Populationen. Ein 22-Pilotprojekt zur Sarkoidose-Neuropathie berichtete \u00fcber einen Unterschied in der Symptombewertung, w\u00e4hrend in einer 9-Studie zu Diabetikern und Makula\u00f6demen die wichtigsten Augenmessungen verfehlt wurden.<\/p>","protected":false},"author":1,"featured_media":2772,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"pim_family_ids":"315","pim_article_type":"Published evidence review","pim_evidence_level":"Small exploratory human trials; mixed endpoints and no confirmatory efficacy record","pim_reviewer":"Site evidence editorial team","pim_reviewed_date":"2026-09-02","pim_editorial_note":"Source-checked on 2026-09-02. Null results, study size, model\/population limits and relevant conflicts are retained. This is not medical advice, a customer case or validation of a catalog lot.","pim_review_status":"reviewed","pim_review_reason":"Primary\/regulatory sources, factual claims, numerical results, limitations and product-evidence boundary checked for batch 3.","pim_creation_method":"The editorial workflow began with linked PubMed primary papers, systematic reviews, PubChem identity records and FDA\/DailyMed regulatory records. Population or model, denominators, endpoints, numerical results, null findings, limitations and conflicts were extracted before drafting. AI-assisted drafting and original image generation were used; the final facts and evidence boundaries were checked against the linked records on 2026-09-02. This is not independent peer review.","pim_sources":"[{\"title\":\"Randomized ARA-290 sarcoidosis-neuropathy pilot\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/23168581\/\",\"note\":\"Primary exploratory trial; PMID 23168581.\"},{\"title\":\"Phase 2 cibinetide diabetic macular edema study\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32674280\/\",\"note\":\"Nine-person study with null principal ocular measures; PMID 32674280.\"},{\"title\":\"PubChem Cibinetide record\",\"url\":\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Cibinetide\",\"note\":\"Sequence, synonyms, formula and mass; CID 91810664.\"}]","footnotes":""},"categories":[19],"tags":[],"class_list":["post-749","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-published-study-cases"],"yoast_head":"\nARA-290\/Cibinetide: Small-Fiber Neuropathy and DME Trial Data<\/title>\n<meta name=\"description\" content=\"Human cibinetide evidence includes small exploratory studies with very different populations. A 22-person sarcoidosis-neuropathy pilot reported a symptom-s\u2026\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nhdbio.com\/de\/ara-290-studien-zu-cibinetid-bei-neuropathie-der-kleinen-nervenfasern-und-dme\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ARA-290\/Cibinetide: Small-Fiber Neuropathy and DME Trial Data\" \/>\n<meta property=\"og:description\" content=\"Human cibinetide evidence includes small exploratory studies with very different populations. A 22-person sarcoidosis-neuropathy pilot reported a symptom-s\u2026\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nhdbio.com\/de\/ara-290-studien-zu-cibinetid-bei-neuropathie-der-kleinen-nervenfasern-und-dme\/\" \/>\n<meta property=\"og:site_name\" content=\"NHD\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-01T16:45:45+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-10-01T14:51:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/cibinetide-small-fiber-evidence.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1672\" \/>\n\t<meta property=\"og:image:height\" content=\"941\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"NHD Technical Team\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Peptide Raw Materials and Custom Peptide Synthesis\" \/>\n<meta name=\"twitter:label1\" content=\"Verfasst von\" \/>\n\t<meta name=\"twitter:data1\" content=\"NHD Technical Team\" \/>\n\t<meta name=\"twitter:label2\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data2\" content=\"1\u00a0Minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ara-290-cibinetide-small-fiber-neuropathy-and-dme-trials\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ara-290-cibinetide-small-fiber-neuropathy-and-dme-trials\\\/\"},\"author\":{\"name\":\"NHD Technical Team\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\"},\"headline\":\"ARA-290\\\/Cibinetide: Small-Fiber Neuropathy and DME Trial Data\",\"datePublished\":\"2026-09-01T16:45:45+00:00\",\"dateModified\":\"2026-10-01T14:51:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ara-290-cibinetide-small-fiber-neuropathy-and-dme-trials\\\/\"},\"wordCount\":298,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ara-290-cibinetide-small-fiber-neuropathy-and-dme-trials\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/cibinetide.webp\",\"articleSection\":[\"Published Study Reviews\"],\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/ara-290-cibinetide-small-fiber-neuropathy-and-dme-trials\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ara-290-cibinetide-small-fiber-neuropathy-and-dme-trials\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/ara-290-cibinetide-small-fiber-neuropathy-and-dme-trials\\\/\",\"name\":\"ARA-290\\\/Cibinetide: Small-Fiber Neuropathy and DME Trial Data\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ara-290-cibinetide-small-fiber-neuropathy-and-dme-trials\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ara-290-cibinetide-small-fiber-neuropathy-and-dme-trials\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/cibinetide.webp\",\"datePublished\":\"2026-09-01T16:45:45+00:00\",\"dateModified\":\"2026-10-01T14:51:45+00:00\",\"description\":\"Human cibinetide evidence includes small exploratory studies with very different populations. A 22-person sarcoidosis-neuropathy pilot reported a symptom-s\u2026\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ara-290-cibinetide-small-fiber-neuropathy-and-dme-trials\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/ara-290-cibinetide-small-fiber-neuropathy-and-dme-trials\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ara-290-cibinetide-small-fiber-neuropathy-and-dme-trials\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/cibinetide.webp\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/cibinetide.webp\",\"width\":1536,\"height\":1024,\"caption\":\"AI-generated editorial illustration.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ara-290-cibinetide-small-fiber-neuropathy-and-dme-trials\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nhdbio.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ARA-290\\\/Cibinetide: Small-Fiber Neuropathy and DME Trial Data\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"name\":\"NHD\",\"description\":\"Peptide Raw Materials and Custom Peptide Synthesis\",\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nhdbio.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\",\"name\":\"NHD\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"width\":2172,\"height\":724,\"caption\":\"NHD\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\",\"name\":\"NHD Technical Team\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"caption\":\"NHD Technical Team\"},\"description\":\"NHD Technical Team maintains research-use catalog documentation and evidence summaries. Reviewed articles link to peer-reviewed papers, trial registries and regulatory records, retain null findings and study limitations, and distinguish published interventions from catalog materials. AI-assisted drafting may be used for structure; source links and evidence boundaries remain visible. This work is not independent peer review or medical advice.\",\"sameAs\":[\"https:\\\/\\\/nhdbio.com\"],\"url\":\"https:\\\/\\\/nhdbio.com\\\/de\\\/author\\\/qianmiao-technical-team\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"ARA-290\/Cibinetide: Small-Fiber-Neuropathie und DME-Studiendaten","description":"Die Evidenz f\u00fcr humanes Cibinetid umfasst kleine explorative Studien mit sehr unterschiedlichen Populationen. Ein 22-Personen-Sarkoidose-Neuropathie-Pilot berichtete \u00fcber Symptome \u2026","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nhdbio.com\/de\/ara-290-studien-zu-cibinetid-bei-neuropathie-der-kleinen-nervenfasern-und-dme\/","og_locale":"de_DE","og_type":"article","og_title":"ARA-290\/Cibinetide: Small-Fiber Neuropathy and DME Trial Data","og_description":"Human cibinetide evidence includes small exploratory studies with very different populations. A 22-person sarcoidosis-neuropathy pilot reported a symptom-s\u2026","og_url":"https:\/\/nhdbio.com\/de\/ara-290-studien-zu-cibinetid-bei-neuropathie-der-kleinen-nervenfasern-und-dme\/","og_site_name":"NHD","article_published_time":"2026-09-01T16:45:45+00:00","article_modified_time":"2026-10-01T14:51:45+00:00","og_image":[{"width":1672,"height":941,"url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/cibinetide-small-fiber-evidence.webp","type":"image\/webp"}],"author":"NHD Technical Team","twitter_card":"summary_large_image","twitter_description":"Peptide Raw Materials and Custom Peptide Synthesis","twitter_misc":{"Verfasst von":"NHD Technical Team","Gesch\u00e4tzte Lesezeit":"1\u00a0Minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nhdbio.com\/ara-290-cibinetide-small-fiber-neuropathy-and-dme-trials\/#article","isPartOf":{"@id":"https:\/\/nhdbio.com\/ara-290-cibinetide-small-fiber-neuropathy-and-dme-trials\/"},"author":{"name":"NHD Technical Team","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1"},"headline":"ARA-290\/Cibinetide: Small-Fiber Neuropathy and DME Trial Data","datePublished":"2026-09-01T16:45:45+00:00","dateModified":"2026-10-01T14:51:45+00:00","mainEntityOfPage":{"@id":"https:\/\/nhdbio.com\/ara-290-cibinetide-small-fiber-neuropathy-and-dme-trials\/"},"wordCount":298,"commentCount":0,"publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"image":{"@id":"https:\/\/nhdbio.com\/ara-290-cibinetide-small-fiber-neuropathy-and-dme-trials\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/10\/cibinetide.webp","articleSection":["Published Study Reviews"],"inLanguage":"de","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/nhdbio.com\/ara-290-cibinetide-small-fiber-neuropathy-and-dme-trials\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/nhdbio.com\/ara-290-cibinetide-small-fiber-neuropathy-and-dme-trials\/","url":"https:\/\/nhdbio.com\/ara-290-cibinetide-small-fiber-neuropathy-and-dme-trials\/","name":"ARA-290\/Cibinetide: Small-Fiber-Neuropathie und DME-Studiendaten","isPartOf":{"@id":"https:\/\/nhdbio.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nhdbio.com\/ara-290-cibinetide-small-fiber-neuropathy-and-dme-trials\/#primaryimage"},"image":{"@id":"https:\/\/nhdbio.com\/ara-290-cibinetide-small-fiber-neuropathy-and-dme-trials\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/10\/cibinetide.webp","datePublished":"2026-09-01T16:45:45+00:00","dateModified":"2026-10-01T14:51:45+00:00","description":"Die Evidenz f\u00fcr humanes Cibinetid umfasst kleine explorative Studien mit sehr unterschiedlichen Populationen. Ein 22-Personen-Sarkoidose-Neuropathie-Pilot berichtete \u00fcber Symptome \u2026","breadcrumb":{"@id":"https:\/\/nhdbio.com\/ara-290-cibinetide-small-fiber-neuropathy-and-dme-trials\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nhdbio.com\/ara-290-cibinetide-small-fiber-neuropathy-and-dme-trials\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/nhdbio.com\/ara-290-cibinetide-small-fiber-neuropathy-and-dme-trials\/#primaryimage","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/10\/cibinetide.webp","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/10\/cibinetide.webp","width":1536,"height":1024,"caption":"AI-generated editorial illustration."},{"@type":"BreadcrumbList","@id":"https:\/\/nhdbio.com\/ara-290-cibinetide-small-fiber-neuropathy-and-dme-trials\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nhdbio.com\/"},{"@type":"ListItem","position":2,"name":"ARA-290\/Cibinetide: Small-Fiber Neuropathy and DME Trial Data"}]},{"@type":"WebSite","@id":"https:\/\/nhdbio.com\/#website","url":"https:\/\/nhdbio.com\/","name":"NHD","description":"Peptidrohstoffe und individuelle Peptidsynthese","publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nhdbio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Organization","@id":"https:\/\/nhdbio.com\/#organization","name":"NHD","url":"https:\/\/nhdbio.com\/","logo":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","width":2172,"height":724,"caption":"NHD"},"image":{"@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1","name":"NHD Technisches Team","image":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","caption":"NHD Technical Team"},"description":"Das technische Team von NHD verwaltet Katalogdokumentationen und Beweiszusammenfassungen f\u00fcr Forschungszwecke. Rezensierte Artikel verweisen auf von Experten begutachtete Artikel, Studienregister und beh\u00f6rdliche Aufzeichnungen, behalten Nullergebnisse und Studieneinschr\u00e4nkungen bei und unterscheiden ver\u00f6ffentlichte Interventionen von Katalogmaterialien. F\u00fcr die Strukturierung kann AI-unterst\u00fctztes Zeichnen verwendet werden; Quellenverkn\u00fcpfungen und Beweisgrenzen bleiben sichtbar. Bei dieser Arbeit handelt es sich nicht um eine unabh\u00e4ngige Begutachtung oder medizinische Beratung.","sameAs":["https:\/\/nhdbio.com"],"url":"https:\/\/nhdbio.com\/de\/author\/qianmiao-technical-team\/"}]}},"_links":{"self":[{"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/posts\/749","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/comments?post=749"}],"version-history":[{"count":1,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/posts\/749\/revisions"}],"predecessor-version":[{"id":2802,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/posts\/749\/revisions\/2802"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/media\/2772"}],"wp:attachment":[{"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/media?parent=749"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/categories?post=749"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/tags?post=749"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}